Hong-Yu Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hong-Yu Zou has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Bing Cao
Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China
1 shared publicationChen-Xuan Lu
Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China
1 shared publicationNa Wang
Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China
1 shared publicationQian-Ying Li
Department of Laboratory Medicine, Jiulongpo District Psychiatric Health Center of Chongqing, Chongqing 401329, China
1 shared publicationYan Huang
Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China
1 shared publicationYuan-Li Liu
Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China
1 shared publication
Latest Publications
- Open Access
- 19 May 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Psychiatry
- Vol. 15 (5) , 102618
Alterations of serum metabolic profile in major depressive disorder: A case-control study in the Chinese population
BACKGROUND Major depressive disorder (MDD) is characterized by persistent depressed mood and cognitive symptoms. This study aimed to discover biomarkers for MDD, explore its pathological mechanisms, and examine the associations of the identified biomarkers with clinical and psychological variables. AIM To discover candidate biomarkers for MDD identification and provide insight into the pathological mechanism of MDD. METHODS The current study adopted a single-center cross-sectional case-control design. Serum samples were obtained from 100 individuals diagnosed with MDD and 97 healthy controls (HCs) aged between 18 to 60 years. Metabolomics was performed on an Ultimate 3000 UHPLC system coupled with Q-Exactive MS (Thermo Scientific). The online software Metaboanalyst 6.0 was used to process and analyze the acquired raw data of peak intensities from the instrument. RESULTS The study included 100 MDD patients and 97 HCs. Metabolomic profiling identified 35 significantly different metabolites (e.g. , cortisol, sebacic acid, and L-glutamic acid). Receiver operating characteristic curve analysis highlighted 8-HETE, 10-HDoHE, cortisol, 12-HHTrE, and 10-hydroxydecanoic acid as top diagnostic biomarkers for MDD. Significant correlations were found between metabolites (e.g. , some lipids, steroids, and amino acids) and clinical and psychological variables. CONCLUSION Our study reported metabolites (some lipids, steroids, amino acids, carnitines, and alkaloids) responsible for discriminating MDD patients and HCs. This metabolite profile may enable the development of a laboratory-based diagnostic test for MDD. The mechanisms underlying the association between psychological or clinical variables and differential metabolites deserve further exploration.
- 19 May 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Psychiatry
- Vol. 15 (5) , 102618
Open AccessAlterations of serum metabolic profile in major depressive disorder: A case-control study in the Chinese population
BACKGROUND Major depressive disorder (MDD) is characterized by persistent depressed mood and cognitive symptoms. This study aimed to discover biomarkers for MDD, explore its pathological mechanisms, and examine the associations of the identified biomarkers with clinical and psychological variables. AIM To discover candidate biomarkers for MDD identification and provide insight into the pathological mechanism of MDD. METHODS The current study adopted a single-center cross-sectional case-control design. Serum samples were obtained from 100 individuals diagnosed with MDD and 97 healthy controls (HCs) aged between 18 to 60 years. Metabolomics was performed on an Ultimate 3000 UHPLC system coupled with Q-Exactive MS (Thermo Scientific). The online software Metaboanalyst 6.0 was used to process and analyze the acquired raw data of peak intensities from the instrument. RESULTS The study included 100 MDD patients and 97 HCs. Metabolomic profiling identified 35 significantly different metabolites (e.g. , cortisol, sebacic acid, and L-glutamic acid). Receiver operating characteristic curve analysis highlighted 8-HETE, 10-HDoHE, cortisol, 12-HHTrE, and 10-hydroxydecanoic acid as top diagnostic biomarkers for MDD. Significant correlations were found between metabolites (e.g. , some lipids, steroids, and amino acids) and clinical and psychological variables. CONCLUSION Our study reported metabolites (some lipids, steroids, amino acids, carnitines, and alkaloids) responsible for discriminating MDD patients and HCs. This metabolite profile may enable the development of a laboratory-based diagnostic test for MDD. The mechanisms underlying the association between psychological or clinical variables and differential metabolites deserve further exploration.